ramucirumab,pembrolizumab
eli lilly,Merck
['lcsm,(-blcsm)', 'lung', 'sclc', 'nsclc', 'improve', 'ramucirumab']
 #asco22 simultaneous pub: lung-map study finds ramucirumab pembro improved os in pts w #nsclc previously treated w/ immune point inhibitors &amp; chemo. #lcsm
@ASCO's credible, authoritative resource for disseminating clinical oncology research. Home of @JCOOP_ASCO, @JCOGO_ASCO, @JCOCCI_ASCO, & @JCOPO_ASCO.